The recent discovery that angiotensin-converting enzyme 2 (ACE2) is an ISG (108) has expanded the therapeutic understanding of IFNs role in the COVID-19 treatment because ACE2 is essential for pulmonary and systemic homeostasis in health and in disease conditions (109). This evidence concerns the gene ACE2 and COVID-19.